Loading...
0

China Oncology Drugs Market Expected to Reach $12,688 Million by 2026

 
 

quote The growth in China oncology drugs market is due to rise in aging population, westernized diet, shift to sedentary lifestyle and rising tobacco smoke exposure in China. Furthermore, rise in cancer awareness and availability of cancer drugs are expected to boost the market growth of the China oncology drugs market. quote

According to Onkar Sumant
Assistant Manager, Healthcare at Allied Market Research

Get 20% Free Customization In This Report
Follow us on Social Media:       
 

According to a new report published by Allied Market Research, titled, "China Oncology Drugs Market by Drug Class and Indication: Opportunity Analysis and Industry Forecast, 2018-2026," the China oncology drugs market size is expected to reach $12,688 million by 2026, registering a CAGR of 8.7% from 2019 to 2026, in terms of value. 

Cancer is caused when the cells present in the body grow at an uncontrolled rate leading to the formation of a tumor. It has different stages based on its progression. Metastasis is the final stage of the disease, which is marked by the invasion of tumor into other parts of body. The management of cancer in patients requires the use of different drugs such as hormonal therapy, immunotherapy, targeted therapy, and others. 
The key drivers of the China oncology drug market are surge in geriatric population and rise in collaborations & partnerships to facilitate drug development. In addition, surge in prevalence of cancer and increase in healthcare expenditure have significantly contributed toward the growth of this market. Increase in number of pipeline drugs along with high potential of emerging economies are further expected to provide lucrative opportunities for market expansion. However, adverse effects related to cancer drugs impede the market growth.

The China oncology drugs market is segmented based on drug class type and indication. Based on drug class type, the market is divided into chemotherapy, targeted therapy, immunotherapy, and hormonal therapy. By indication, it is categorized into blood cancer, breast cancer, gastrointestinal cancer, prostate cancer, lung cancer, skin cancer, ovarian cancer, cervical cancer, kidney cancer, and other cancers. 

Key Benefits for China Oncology Drugs Market:

  • Lung cancer occupied 18.32% share of the China cancer drugs market in 2018.
  • The breast cancer segment is anticipated to grow with the highest CAGR throughout the forecast period.
  • The targeted therapy segment accounted for 42.35% share of the China oncology drugs market in 2018. 
  • Immunotherapy segment is anticipated to grow at the highest rate during the analysis period.

Major players operating in the China oncology drugs market include AbbVie Inc., Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Celgene Corporation, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Shanghai Junshi Biosciences Co., Ltd., Beigene and Jiangsu Hengrui Medicine Co., Ltd.
 

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com

 

For Media Inquiries, Please Contact

Shaun Godinho
Communications Officer
Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com

 
 

First time buyer?
Check offers and discount on this report
To get this report

 
Click Here
 
 

quote China Oncology Drugs Market by Drug Class Type (Chemotherapy, Targeted Therapy, Immunotherapy, and Hormonal Therapy) and Indication (Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Lung Cancer, Skin Cancer, Ovarian Cancer, Cervical Cancer, Kidney Cancer, and Other Cancers): Opportunity Analysis and Industry Forecast, 2019-2026 quote

View Report
 
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time of readers

 

Featured Readings

 
 

Get Fresh content delivered

Get insights on topics that matter to your business. Stay updated on the area that interests you.

 
Get Industry Data Alerts
 

Buy Full Version
"China Oncology Drugs Market"
Purchase Enquiry